Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects in Patients Chronic Kidney Disease With Cardiovascular Disease /Heart Failure
Latest Information Update: 31 Dec 2025
At a glance
- Drugs Vicadrostat (Primary) ; Empagliflozin; Spironolactone
- Indications Cardiovascular disorders; Heart failure
- Focus Pharmacodynamics
- Acronyms COMPARE-VS
Most Recent Events
- 31 Dec 2025 New trial record